1,2-dimethylhydrazine decreases expression ISO RGD:732736 6480464 1, 2-Dimethylhydrazine results in decreased expression of IL13RA1 mRNA CTD PMID:22206623 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1347132 6480464 Tetrachlorodibenzodioxin results in decreased expression of IL13RA1 mRNA CTD PMID:17101203 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IL13RA1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732736 6480464 Tetrachlorodibenzodioxin affects the expression of IL13RA1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732736 6480464 Tetrachlorodibenzodioxin results in decreased expression of IL13RA1 mRNA CTD PMID:15652763 more ... 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of IL13RA1 mRNA CTD PMID:21346803 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of IL13RA1 mRNA] CTD PMID:17109745 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of IL13RA1 mRNA CTD PMID:17109745 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of IL13RA1 mRNA CTD PMID:28522335 4,4'-sulfonyldiphenol increases expression ISO RGD:732736 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of IL13RA1 mRNA CTD PMID:30951980 4-hydroxynon-2-enal decreases expression ISO RGD:732736 6480464 4-hydroxy-2-nonenal results in decreased expression of IL13RA1 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:732736 6480464 Fenretinide results in increased expression of IL13RA1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO RGD:1347132 6480464 Decitabine results in increased expression of IL13RA1 mRNA CTD PMID:20381863 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of IL13RA1 mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of IL13RA1 mRNA CTD PMID:31881176 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of IL13RA1 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:732736 6480464 Aflatoxin B1 results in increased expression of IL13RA1 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1347132 6480464 Aflatoxin B1 results in decreased methylation of IL13RA1 gene CTD PMID:27153756 aldehydo-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of IL13RA1 mRNA] CTD PMID:17109745 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of IL13RA1 mRNA CTD PMID:17109745 all-trans-retinoic acid increases expression ISO RGD:1347132 6480464 Tretinoin results in increased expression of IL13RA1 mRNA CTD PMID:21934132 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of IL13RA1 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of IL13RA1 mRNA CTD PMID:30779732 benzene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of IL13RA1 mRNA CTD PMID:17905399 benzo[a]pyrene decreases expression ISO RGD:732736 6480464 Benzo(a)pyrene results in decreased expression of IL13RA1 mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation ISO RGD:1347132 6480464 Benzo(a)pyrene results in decreased methylation of IL13RA1 3' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1347132 6480464 Benzo(a)pyrene affects the methylation of IL13RA1 exon, Benzo(a)pyrene affects the methylation of IL13RA1 promoter CTD PMID:27901495 beta-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of IL13RA1 mRNA] CTD PMID:17109745 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of IL13RA1 mRNA CTD PMID:17109745 bisphenol A decreases expression ISO RGD:1347132 6480464 bisphenol A results in decreased expression of IL13RA1 mRNA CTD PMID:22576693 bisphenol A multiple interactions ISO RGD:1347132 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of IL13RA1 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IL13RA1 mRNA CTD PMID:34947998 bisphenol A increases expression ISO RGD:732736 6480464 bisphenol A results in increased expression of IL13RA1 mRNA CTD PMID:30951980 , PMID:32156529 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of IL13RA1 mRNA CTD PMID:30816183 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of IL13RA1 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:1347132 6480464 bisphenol A results in increased methylation of IL13RA1 gene CTD PMID:22576693 bisphenol F increases expression ISO RGD:732736 6480464 bisphenol F results in increased expression of IL13RA1 mRNA CTD PMID:30951980 bleomycin A2 multiple interactions ISO RGD:732736 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of IL13RA1 mRNA], lenabasum inhibits the reaction [Bleomycin results in increased expression of IL13RA1 mRNA] CTD PMID:30825431 bleomycin A2 increases expression ISO RGD:732736 6480464 Bleomycin results in increased expression of IL13RA1 mRNA CTD PMID:30825431 , PMID:36087614 butanal decreases expression ISO RGD:1347132 6480464 butyraldehyde results in decreased expression of IL13RA1 mRNA CTD PMID:26079696 cadmium atom decreases expression ISO RGD:1347132 6480464 Cadmium results in decreased expression of IL13RA1 mRNA CTD PMID:23369406 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of IL13RA1 mRNA CTD PMID:25993096 Calcimycin multiple interactions ISO RGD:1347132 6480464 [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13RA1 mRNA, fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13RA1 mRNA] CTD PMID:21331654 cannabidiol decreases expression ISO RGD:1347132 6480464 Cannabidiol results in decreased expression of IL13RA1 mRNA CTD PMID:27932991 cannabidiol multiple interactions ISO RGD:732736 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of IL13RA1 mRNA] CTD PMID:30825431 carbamazepine affects expression ISO RGD:1347132 6480464 Carbamazepine affects the expression of IL13RA1 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:732736 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:1347132 6480464 CGP 52608 promotes the reaction [RORA protein binds to IL13RA1 gene] CTD PMID:28238834 choline multiple interactions ISO RGD:732736 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IL13RA1 gene CTD PMID:20938992 chromium(6+) affects expression ISO RGD:732736 6480464 chromium hexavalent ion affects the expression of IL13RA1 mRNA CTD PMID:28472532 cisplatin decreases response to substance ISO RGD:1347132 6480464 IL13RA1 protein results in decreased susceptibility to Cisplatin CTD PMID:16734730 cisplatin increases expression ISO RGD:1347132 6480464 Cisplatin results in increased expression of IL13RA1 mRNA CTD PMID:27594783 copper(II) sulfate decreases expression ISO RGD:1347132 6480464 Copper Sulfate results in decreased expression of IL13RA1 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of IL13RA1 mRNA CTD PMID:27523638 cyclophosphamide increases expression ISO RGD:732736 6480464 Cyclophosphamide results in increased expression of IL13RA1 mRNA CTD PMID:21041162 cyclosporin A decreases expression ISO RGD:1347132 6480464 Cyclosporine results in decreased expression of IL13RA1 mRNA CTD PMID:20106945 dexamethasone increases expression ISO RGD:732736 6480464 Dexamethasone results in increased expression of IL13RA1 mRNA CTD PMID:21041162 dibutyl phthalate increases expression ISO RGD:732736 6480464 Dibutyl Phthalate results in increased expression of IL13RA1 mRNA CTD PMID:21266533 diclofenac increases expression ISO RGD:732736 6480464 Diclofenac results in increased expression of IL13RA1 mRNA CTD PMID:26934552 dioxygen increases expression ISO RGD:732736 6480464 Oxygen deficiency results in increased expression of IL13RA1 mRNA CTD PMID:20880076 dioxygen multiple interactions ISO RGD:732736 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL13RA1 mRNA, HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of IL13RA1 mRNA] CTD PMID:20880076 , PMID:30529165 diuron decreases expression EXP 6480464 Diuron results in decreased expression of IL13RA1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1347132 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1347132 6480464 Doxorubicin results in decreased expression of IL13RA1 mRNA CTD PMID:29803840 ethyl methanesulfonate increases expression ISO RGD:1347132 6480464 Ethyl Methanesulfonate results in increased expression of IL13RA1 mRNA CTD PMID:23649840 fenthion decreases expression ISO RGD:732736 6480464 Fenthion results in decreased expression of IL13RA1 mRNA CTD PMID:34813904 ferulic acid multiple interactions ISO RGD:732736 6480464 ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL13RA1 mRNA] CTD PMID:31054998 fipronil increases expression EXP 6480464 fipronil results in increased expression of IL13RA1 mRNA CTD PMID:23962444 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of IL13RA1 mRNA CTD PMID:34044035 fluoranthene multiple interactions ISO RGD:732736 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of IL13RA1 mRNA CTD PMID:28329830 flutamide increases expression EXP 6480464 Flutamide results in increased expression of IL13RA1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:732736 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IL13RA1 gene CTD PMID:20938992 formaldehyde increases expression ISO RGD:1347132 6480464 Formaldehyde results in increased expression of IL13RA1 mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:1347132 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of IL13RA1 gene CTD PMID:31601247 furan increases methylation EXP 6480464 furan results in increased methylation of IL13RA1 gene CTD PMID:22079235 heptachlor decreases expression EXP 6480464 Heptachlor results in decreased expression of IL13RA1 mRNA CTD PMID:23153324 imiquimod multiple interactions ISO RGD:732736 6480464 ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL13RA1 mRNA] CTD PMID:31054998 imiquimod increases expression ISO RGD:732736 6480464 Imiquimod results in increased expression of IL13RA1 mRNA CTD PMID:31054998 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of IL13RA1 mRNA CTD PMID:20097248 isotretinoin decreases expression ISO RGD:1347132 6480464 Isotretinoin results in decreased expression of IL13RA1 mRNA CTD PMID:20436886 L-methionine multiple interactions ISO RGD:732736 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IL13RA1 gene CTD PMID:20938992 lipopolysaccharide multiple interactions ISO RGD:732736 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of IL13RA1 mRNA] CTD PMID:26582142 lipopolysaccharide increases expression ISO RGD:732736 6480464 Lipopolysaccharides results in increased expression of IL13RA1 mRNA CTD PMID:26582142 mercury dibromide increases expression ISO RGD:1347132 6480464 mercuric bromide results in increased expression of IL13RA1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1347132 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL13RA1 mRNA CTD PMID:27188386 methotrexate increases expression ISO RGD:1347132 6480464 Methotrexate results in increased expression of IL13RA1 mRNA CTD PMID:21678067 methyl methanesulfonate increases expression ISO RGD:1347132 6480464 Methyl Methanesulfonate results in increased expression of IL13RA1 mRNA CTD PMID:23649840 methylmercury(1+) multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of IL13RA1 mRNA CTD PMID:17905399 mycotoxin increases expression ISO RGD:732736 6480464 Mycotoxins results in increased expression of IL13RA1 mRNA CTD PMID:19818335 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO RGD:1347132 6480464 N more ... CTD PMID:19013360 N-methyl-4-phenylpyridinium increases expression ISO RGD:1347132 6480464 1-Methyl-4-phenylpyridinium results in increased expression of IL13RA1 mRNA CTD PMID:24810058 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of IL13RA1 mRNA CTD PMID:24136188 nickel atom increases expression ISO RGD:1347132 6480464 Nickel results in increased expression of IL13RA1 mRNA CTD PMID:25583101 nickel sulfate increases expression ISO RGD:1347132 6480464 nickel sulfate results in increased expression of IL13RA1 mRNA CTD PMID:22714537 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IL13RA1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:732736 6480464 [Soot co-treated with Ozone] results in increased expression of IL13RA1 mRNA CTD PMID:36303316 paracetamol affects expression ISO RGD:732736 6480464 Acetaminophen affects the expression of IL13RA1 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1347132 6480464 Acetaminophen results in decreased expression of IL13RA1 mRNA CTD PMID:31059760 phenobarbital multiple interactions ISO RGD:732736 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of IL13RA1 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:732736 6480464 Phenobarbital affects the expression of IL13RA1 mRNA CTD PMID:23091169 phenobarbital decreases expression ISO RGD:732736 6480464 Phenobarbital results in decreased expression of IL13RA1 mRNA CTD PMID:19482888 phenylmercury acetate increases expression ISO RGD:1347132 6480464 Phenylmercuric Acetate results in increased expression of IL13RA1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1347132 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL13RA1 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1347132 6480464 [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13RA1 mRNA, fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13RA1 mRNA] CTD PMID:21331654 pirinixic acid decreases expression ISO RGD:732736 6480464 pirinixic acid results in decreased expression of IL13RA1 mRNA CTD PMID:23811191 potassium chromate decreases expression ISO RGD:1347132 6480464 potassium chromate(VI) results in decreased expression of IL13RA1 mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:732736 6480464 Pregnenolone Carbonitrile results in increased expression of IL13RA1 mRNA CTD PMID:27413110 , PMID:28903501 progesterone decreases expression ISO RGD:1347132 6480464 Progesterone results in decreased expression of IL13RA1 mRNA CTD PMID:21795739 progesterone increases expression EXP 6480464 Progesterone results in increased expression of IL13RA1 mRNA CTD PMID:21770760 protein kinase inhibitor multiple interactions ISO RGD:1347132 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of IL13RA1 mRNA] CTD PMID:28003376 SB 431542 multiple interactions ISO RGD:1347132 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 senecionine decreases expression ISO RGD:732736 6480464 senecionine results in decreased expression of IL13RA1 protein CTD PMID:35357534 silicon dioxide decreases expression ISO RGD:732736 6480464 Silicon Dioxide results in decreased expression of IL13RA1 mRNA CTD PMID:19073995 sodium arsenate increases expression ISO RGD:732736 6480464 sodium arsenate results in increased expression of IL13RA1 mRNA CTD PMID:21795629 sodium arsenite increases expression ISO RGD:1347132 6480464 sodium arsenite results in increased expression of IL13RA1 mRNA CTD PMID:22714537 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of IL13RA1 mRNA CTD PMID:25993096 Soman increases expression EXP 6480464 Soman results in increased expression of IL13RA1 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:732736 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IL13RA1 mRNA CTD PMID:21641980 sulindac sulfide decreases expression ISO RGD:1347132 6480464 sulindac sulfide results in decreased expression of IL13RA1 mRNA CTD PMID:16184548 sunitinib decreases expression ISO RGD:1347132 6480464 Sunitinib results in decreased expression of IL13RA1 mRNA CTD PMID:31533062 temozolomide decreases expression ISO RGD:1347132 6480464 Temozolomide results in decreased expression of IL13RA1 mRNA CTD PMID:31758290 tetrachloromethane affects expression ISO RGD:732736 6480464 Carbon Tetrachloride affects the expression of IL13RA1 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:732736 6480464 Carbon Tetrachloride results in increased expression of IL13RA1 mRNA CTD PMID:18263696 thimerosal decreases expression ISO RGD:1347132 6480464 Thimerosal results in decreased expression of IL13RA1 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of IL13RA1 mRNA CTD PMID:34492290 titanium dioxide affects expression ISO RGD:732736 6480464 titanium dioxide affects the expression of IL13RA1 mRNA CTD PMID:23557971 toluene increases expression EXP 6480464 Toluene results in increased expression of IL13RA1 mRNA CTD PMID:22967744 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IL13RA1 mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:1347132 6480464 torcetrapib results in increased expression of IL13RA1 mRNA CTD PMID:23228038 trichloroethene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of IL13RA1 mRNA CTD PMID:17905399 trichostatin A increases expression ISO RGD:1347132 6480464 trichostatin A results in increased expression of IL13RA1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1347132 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL13RA1 mRNA CTD PMID:27188386 urethane decreases expression ISO RGD:1347132 6480464 Urethane results in decreased expression of IL13RA1 mRNA CTD PMID:28818685 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of IL13RA1 mRNA CTD PMID:24136188 valproic acid decreases methylation ISO RGD:1347132 6480464 Valproic Acid results in decreased methylation of IL13RA1 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1347132 6480464 Valproic Acid results in increased expression of IL13RA1 mRNA CTD PMID:28001369 valproic acid affects expression ISO RGD:1347132 6480464 Valproic Acid affects the expression of IL13RA1 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of IL13RA1 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of IL13RA1 mRNA CTD PMID:23555832 vitamin E increases expression ISO RGD:1347132 6480464 Vitamin E results in increased expression of IL13RA1 mRNA CTD PMID:19244175